info@emcapital.com.hk
(852) 2960 2388

自中国政府上一个“十二五”计划以来,生物科技一直是主要目标,其中1.7万亿资金注入该行业。为了在最近的“十叁五”规划中通过扩大新一代生物科技产品和服务来扩大行业规模,国家继续推动中国的製药创新。

自中國政府上一個“十二五”計劃以來,生物科技一直是主要目標,其中1.7萬億資金注入該行業。為了在最近的“十三五”規劃中通過擴大新一代生物科技產品和服務來擴大行業規模,國家繼續推動中國的製藥創新。

Biotechnology industry has been the main target since Chinese government’s previous plan, 12th FYP, where 1.7 trillion was injected into this industry. With the goal of doubling the industry’s scale through scaling up of a new generation of biotechnology products and services in its recent 13th FYP, China’s pharma innovation continues to spur through strong state support.